? CORE C The ACCESS-GI (Advanced Co-culture Engineering and Single cell Statistics of Gut Immunology) Core C will provide a range of cutting edge approaches to Stanford NAMSED investigators (Projects 1, 2 and pilots) to analyze intestinal/gastric epithelial cells and their interactions with immune cells both with and without infection. In association with the Organoid Core B, we will carry out development work towards the generation of organoids that integrate mucosal immune cells. Specifically, in Aim 1, we will leverage highly multiplexed, single cells analysis (CyTOF mass cytometry) and imaging (multiplexed ion beam imaging ? MIBI) modalities collaboratively developed at Stanford by Sean Bendall to provide cell analysis assays for projects across the NAMSED center (Projects 1, 2). These assays will be uniquely beneficial, allowing the simultaneous characterization of human gut organoid structure, the integration of immune cells, and the effects of pathogens on cellular behavior. Further to this, Core C will facilitate access to other analysis modalities available through Stanford's human immune monitoring core (HIMC), including 63-plex Luminex for quantitative measurement of human cytokines and chemokines, standard ELISA for non-Luminex targets, and Fluidigm Biomark for single cell qPCR analysis. The core will leverage the expertise of Sean Bendall, his team, and the HIMC for analysis of data generated by these platforms and, where appropriate, for multi-platform data integration.
In Aim 2, Sarah Heilshorn and her team will provide novel assays to NAMSED investigators (Projects 1, 2), using microfluidic devices that allow investigation of cell/cell and cell/pathogen interactions in highly controlled micro-environments.
In Aim 3, Elizabeth Mellins and her team, in collaboration with the Organoid Core, will provide M-cell-like organoids to Project 1, and class II expressing organoids and develop production of organoids with physiologic levels of M cells. Her team will also provide homogenous immune cell populations to NAMSED investigators for experiments addressing immune reactivity in the context of infected intestinal organoids (Project 1) as well as study interactions of selected antigen presenting cells with uninfected and infected organoids. The latter will form the foundation of a key effort, in collaboration with the Organoid Core, to develop human intestinal organoids that more closely replicate the physiologic microenvironment encountered by pathogens during enteric infection.

Public Health Relevance

? CORE C The ACCESS-GI Core C will serve to provide the project investigators with state-of-the-art assays to characterize intestinal/gastric cells and their interactions with pathogens and immune cells. In addition, this Core will work with the Organoid Core to develop integrated organoid/immune cell co-cultures that act as 'mini- guts' to study the interaction of intestinal pathogens with the human host.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Program--Cooperative Agreements (U19)
Project #
5U19AI116484-04
Application #
9440972
Study Section
Special Emphasis Panel (ZAI1)
Project Start
Project End
Budget Start
2018-03-01
Budget End
2019-02-28
Support Year
4
Fiscal Year
2018
Total Cost
Indirect Cost
Name
Stanford University
Department
Type
DUNS #
009214214
City
Stanford
State
CA
Country
United States
Zip Code
94304
Wosen, Jonathan E; Mukhopadhyay, Dhriti; Macaubas, Claudia et al. (2018) Epithelial MHC Class II Expression and Its Role in Antigen Presentation in the Gastrointestinal and Respiratory Tracts. Front Immunol 9:2144
Hartmann, Felix J; Simonds, Erin F; Bendall, Sean C (2018) A Universal Live Cell Barcoding-Platform for Multiplexed Human Single Cell Analysis. Sci Rep 8:10770
Ding, Siyuan; Zhu, Shu; Ren, Lili et al. (2018) Rotavirus VP3 targets MAVS for degradation to inhibit type III interferon expression in intestinal epithelial cells. Elife 7:
Haugh, Matthew G; Vaughan, Ted J; Madl, Christopher M et al. (2018) Investigating the interplay between substrate stiffness and ligand chemistry in directing mesenchymal stem cell differentiation within 3D macro-porous substrates. Biomaterials 171:23-33
Keren, Leeat; Bosse, Marc; Marquez, Diana et al. (2018) A Structured Tumor-Immune Microenvironment in Triple Negative Breast Cancer Revealed by Multiplexed Ion Beam Imaging. Cell 174:1373-1387.e19
LeSavage, Bauer L; Suhar, Nicholas A; Madl, Christopher M et al. (2018) Production of Elastin-like Protein Hydrogels for Encapsulation and Immunostaining of Cells in 3D. J Vis Exp :
Madl, Christopher M; Heilshorn, Sarah C; Blau, Helen M (2018) Bioengineering strategies to accelerate stem cell therapeutics. Nature 557:335-342
Nair, Nitya; Feng, Ningguo; Blum, Lisa K et al. (2017) VP4- and VP7-specific antibodies mediate heterotypic immunity to rotavirus in humans. Sci Transl Med 9:
Dubbin, Karen; Tabet, Anthony; Heilshorn, Sarah C (2017) Quantitative criteria to benchmark new and existing bio-inks for cell compatibility. Biofabrication 9:044102
Janda, Claudia Y; Dang, Luke T; You, Changjiang et al. (2017) Surrogate Wnt agonists that phenocopy canonical Wnt and ?-catenin signalling. Nature 545:234-237

Showing the most recent 10 out of 31 publications